Journal of Nanobiotechnology · 2016 · 91 citations · 42 references
Life SciencesDermatologyImmunologyHypersensitivityInflammationNanomaterialsAllergic Skin DiseasesAtopic DermatitisContact DermatitisNanocarriers For TherapeuticsNanomedicineSkin SensitizationAnti-inflammatory NanomaterialsAnti-inflammatory TherapeuticsCytokine-mediated Skin InflammationFullerenesInflammatory Responses To NanoparticlesNanoparticlesPro-inflammatory Cytokine ExpressionSkin-targeted Nanoparticles
BACKGROUND: Water-soluble form of fullerene C60 is a promising tool for the control of ROS-dependent inflammation including allergic diseases. Anti-inflammatory effects of C60 (nC60) aqueous dispersion were evaluated in the mouse models of atopic dermatitis using subcutaneous (SC) and epicutaneous (EC) applications during 50 days period. A highly stable nC60 was prepared by exhaustive dialysis of water-organic C60 solution against water, where the size and ζ-potential of fullerene nanoparticles are about 100 nm and -30 mV, respectively. RESULTS: To induce skin inflammation, female BALB/c mice were EC sensitized with ovalbumin three times during one-weekly exposures. The nC60 solution was administrated in mice subcutaneously (SC) (0.1 mg/kg) and epicutaneously (EC) (1 mg/kg). Significant suppression of IgE and Th2 cytokines production and a concomitant rise in concentrations of Th1 cytokines were observed in nC60-treated groups. In addition, a significant increase in the levels of Foxp3(+) and filaggrin mRNA expression was observed at EC application. Histological examination of skin samples indicated that therapeutic effect was achieved by both EC and SC treatment, but it was more effective with EC. Pronounced reduction of the eosinophil and leukocyte infiltration in treated skin samples was observed. CONCLUSIONS: We suppose that nC60 treatment shifts immune response from Th2 to Th1 and restores to some extent the function of the skin barrier. This approach can be a good alternative to the treatment of allergic and other inflammatory diseases.
42
Thomas Bieber · New England Journal of Medicine · 2008 · 1.8K citations
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li‐Fan Lu, Evan Lind, David Gondek et al. · Nature · 2006 · 745 citations
[60]Fullerene is a Powerful Antioxidant in Vivo with No Acute or Subacute Toxicity
Najla Gharbi, M Pressac, Michelle Hadchouel et al. · Nano Letters · 2005 · 652 citations
Jonathan M. Spergel, Emiko Mizoguchi, Joanne P. Brewer et al. · Journal of Clinical Investigation · 1998 · 637 citations · Full text